Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Observational Study
. 2016 Jan 6;6(1):e009536.
doi: 10.1136/bmjopen-2015-009536.

Infant outcomes after exposure to Tdap vaccine in pregnancy: an observational study

Tony Walls  1 , Patricia Graham  2 , Helen Petousis-Harris  3 , Linda Hill  4 , Nicola Austin  2
Affiliations
Observational Study

Infant outcomes after exposure to Tdap vaccine in pregnancy: an observational study

Tony Walls et al. BMJ Open. .

Abstract

Objective: Pertussis vaccination during pregnancy has recently been recommended in both the USA and UK to prevent pertussis infection in infants. While there are no apparent safety concerns about the administration of Tdap vaccine during pregnancy, there is only limited safety data available. We aimed to closely monitor infants exposed to Tdap during pregnancy to look for any adverse outcomes that may be attributable to the vaccine.

Design: This was a prospective observational study, collecting information to evaluate the safety of Tdap vaccine for infants exposed during pregnancy. Infants were followed for between 6 and 12 months after birth, with 84% completing 12 months of follow-up. Information was obtained from objective sources including routine health visits and vaccination records wherever possible, as well as frequent parental reports.

Setting: The Canterbury region of New Zealand.

Patients: A cohort of 403 infants whose mothers had received Tdap vaccine.

Main outcome measures: Gestational age at birth, growth parameters, congenital anomalies, immunisation status and timeliness of immunisation, development of pertussis infection.

Results: There were no significant differences in birth weight, gestational age at birth, congenital anomalies or infant growth as compared with baseline population data. Infants of mothers who had received the vaccine were more likely to receive their vaccinations on time during infancy. No cases of pertussis occurred in this cohort despite high rates of disease in the community. We have not found any adverse events attributable to vaccine exposure.

Conclusions: These data add to the growing pool of evidence that the administration of Tdap vaccine during pregnancy is an appropriate strategy for reducing the burden of pertussis in infants.

Clinical trial registration: Australia New Zealand Clinical Trials Registry ACTRN12613001045707.

Keywords: INFECTIOUS DISEASES; PUBLIC HEALTH.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Study enrolment (FU, follow-up).
Figure 2
Figure 2
Z-scores for infant weights at birth, 6 weeks and 5–7 months of age.
See this image and copyright information in PMC

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

    1. Healy CM, Munoz FM, Rench MA et al. . Prevalence of pertussis antibodies in maternal delivery, cord, and infant serum. J Infect Dis 2004;190:335–40. 10.1086/421033 - DOI - PubMed
    1. Centers for Disease Control and Prevention CDC. Updated recommendations for use of tetanus toxoid, reduced diphtheria toxoid, and acellular pertussis vaccine (Tdap) in pregnant women—Advisory Committee on Immunization Practices (ACIP), 2012. MMWR Morb Mortal Wkly Rep 2013;62:131–5. - PMC - PubMed
    1. https://www.gov.uk/government/groups/joint-committee-on-vaccination-and-... JCVI meeting on pertussis immunisation: August 2012.
    1. Zheteyeva YA, Moro PL, Tepper NK et al. . Adverse event reports after tetanus toxoid, reduced diphtheria toxoid, and acellular pertussis vaccines in pregnant women. Am J Obstet Gynecol 2012;207:59.e1–7. 10.1016/j.ajog.2012.05.006 - DOI - PubMed
    1. Munoz FM, Bond NH, Maccato M et al. . Safety and immunogenicity of tetanus diphtheria and acellular pertussis (Tdap) immunization during pregnancy in mothers and infants: a randomized clinical trial. JAMA 2014;311:1760–9. 10.1001/jama.2014.3633 - DOI - PMC - PubMed

Publication types

Substances

LinkOut - more resources